Drug
Htx 011a
Htx 011a: highest development phase Phase 2, developed by Heron Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Heron Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| HTX-011A NCT02762929 | Phase 2 | Postoperative Pain |
Latest
No recent events.
Follow Htx 011a on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.